Chang-Ting Lin

First-line Immune Checkpoint Inhibitor Versus Immune Checkpoint Inhibitor With Chemotherapy for Cisplatin-ineligible Metastatic Urothelial Carcinoma: Evidence From a Real-world, Multicenter Analysis

Yu-Li Su, Shi-Yu Huang, Ting-ting Liu, 2022, Journal of immunotherapy.

Pneumothorax during alectinib treatment for a uterine inflammatory myofibroblastic tumor with lung metastasis

Hsuan-Ying Huang, Chien-ting Liu, Chang-Ting Lin, 2023, Journal of Cancer Research and Practice.

The prognostic significance of histologic variant on survival outcomes in patients with metastatic urothelial carcinoma receiving immune checkpoint inhibitor therapy

Yu-Li Su, Hao-Lun Luo, Chia-Che Wu, 2023, BMC Cancer.

The impact of body mass index on survival endpoints among patients with metastatic urothelial carcinoma undergoing treatment with immune checkpoint inhibitors: A real‐world multicenter analysis

Yu-Li Su, Hao-Lun Luo, Yi-Hua Chen, 2024, Cancer medicine.